Day At The Track
Search Results
1 to 7 of 7
1

The New York State Gaming Commission today announced significant, nation-leading action in addressing the presence of the alkaloid glaucine in the urine and plasma of harness racing horses, resulting in more than $100,000 in purses returned and 11 disqualifications, plus additional fines and suspension for a single trainer whose horses had particularly high levels of the substance. Glaucine, also known as Boldine Dimethyl Ether or 1,2,9,10-Tetramethoxyaporphine, is a potent drug with the potential to affect race performance by means of its anti-inflammatory, antitussive, bronchodilatory and hallucinogenic properties. Glaucine has not been approved as a drug for any use by the U.S. Food and Drug Administration. The Association of Racing Commissioners International (ARCI) does not include glaucine in its Uniform Classification Guidelines for Foreign Substances. “New York is once again leading the way when it comes to preserving integrity in horse racing,” said Commission Executive Director Robert Williams. “The Commission took deliberative action based upon solid research to hold trainers accountable for substances found in horses under their care. We call on other jurisdictions around the country to follow suit to send a clear message: we will tolerate nothing short of fair and safe horse racing.” “The New York State Gaming Commission’s action on glaucine preserves the integrity of the internationally renowned horse racing we host in New York State,” said Peter Arrigenna, a prominent New York harness horse owner and Trustee for the Agriculture and New York State Horse Breeding Development Fund (New York Sire Stakes). “Glaucine has been a hot topic in the harness racing world for the past year, and thanks to New York’s prudent action on this substance, the industry has a clear path forward in how to best handle future cases.” Over the past year, the Commission found 55 instances of horses with glaucine in their systems at levels greater than 100 pg/ml. As is standard practice, all impacted horses were immediately put on the Stewards List, which prevents a horse from entering any future races until the horse is tested and found negative for the presence of any illegal substance. Of the 55 instances found by the Commission, 11 were found to have levels higher than 500 pg/ml. For these cases, the Commission ordered that the horses be disqualified from the applicable races and any purses won by the owners of those horses be returned, totaling $103,530. Trainer Richard Johnson twice raced the horse “Rubber Duck” at Yonkers Raceway with glaucine levels far greater than 1 ng/ml. In addition to the disqualification and purse return totaling $61,660, Johnson is facing a 45-day suspension and $1,500 fine. A complete list of horses that had elevated levels of glaucine may be found here. The Commission began finding elevated glaucine levels in January 2016, but reserved issuing rulings pending further investigation. Over the past year, the Commission and the New York Drug Testing and Research Laboratory have collaborated with other jurisdictions and national racing organizations to conduct research on glaucine, which may be naturally found in wood shavings used to line horses’ stalls. New research conducted by New York and Pennsylvania officials substantiate that glaucine levels of 500 pg/ml or greater in a horse on raceday indicate that the horse was introduced to a potentially efficacious dose of the substance on race day. Therefore, the Commission’s Rule 4120.2(n) applies, which states that no drugs or medications – other than those specifically exempted - may be administered by any means within one week of the scheduled post time of the race in which the horse is to compete and that it is the trainer's responsibility to prevent such ingestion within such one-week period. Most recently, the Racing Medication & Testing Consortium’s (RMTC) Glaucine Task Force and Science Advisory Committee – both of which include New York State Equine Medical Director Scott E. Palmer, VMD – recommended applying two thresholds for the presence of glaucine in a race horse. The Commission’s actions today – and going forward – are based on these standards and disqualifying a horse that violates such thresholds: > 500 pg/ml = Disqualification, loss of purse and Stewards List > 1 ng/ml = Disqualification, loss of purse, Stewards List and additional penalties, including fines and suspension The Commission will continue to place horses that test in excess of 100 pg/ml for glaucine on the Stewards List and require those horses to test below such concentration before being permitted to race again. Horses testing in excess of 500 pg/ml will incur penalties as described above. Per Equine Medical Director Dr. Palmer, environmental contamination is avoidable by the adoption of simple stable management practices: ·         Stalls should not be bedded with bulk wood shavings that may contain tulip poplar material on a chronic basis or during the week that a horse races. Do not administer any product or plant material, whether purchased online, compounded or otherwise, that may contain glaucine. NYS Gaming Commission

The New York State Gaming Commission has received at least 35 written reports from its own highly regarded testing laboratory regarding positive tests for Glaucine at New York State tracks.  Other jurisdictions have reported similar positives.  Not only hasn't the Gaming Commission taken any action to call for the return of purse money, much less done anything as required by its regulations; now the Commission has apparently decided that there is some reason to have RMTC ((Racing Medication and Testing Consortium) conduct "research" on Glaucine. The drug is manufactured, and generally available, outside the United States. This has been done despite the Gaming Commission's research lab coming to its own conclusions; something in the past always deemed more than satisfactory. Meanwhile, with no action taken, positive tests continue to be reported in New York and other jurisdictions.  Presumptively, RMTC will issue a report about this drug at some point in time, but more time will obviously pass.  One has to wonder why this unprecedented action is being done via RMTC, and what data is being shared or withheld from RMTC? RMTC was formed with the intent of developing a Controlled Therapeutic Medication Schedule (CTMS) to achieve uniformity in the use of therapeutic medications in race horses, while preventing medications and drugs from unduly influencing the outcome of races.  The RMTC does not have a very good track record achieving its goals, and its scientific work in establishing thresholds has often left much to be desired.  Dr. Scott Palmer, the New York Gaming Commission's Equine Medical Director who sits on the newly announced Task Force, certainly knows that to be the case. In the past, RMTC sought to provide a guideline to the New York Gaming Commission to adopt for all breeds for Flunixin (Banamine) and for Clenbuterol for harness horses. The recommendations were not only contrary to some of RMTC’s own scientific guidelines; its research, such as it is, remains  hidden under a "confidentiality" agreement which prevents RMTC's members from divulging even the research they reviewed, much less the scientific basis for their determinations of those thresholds.  It is, of course, intuitively obvious that undisclosed, unpublished research can never fail to pass peer review. Had the New York State Gaming Commission adopted those RMTC thresholds, New York horsemen would have suffered false positives, because the RMTC guidelines were, in point of scientific fact, erroneous, and later corrected.  By way of example, in 2013, RMTC adopted a threshold for Xylazine (Rompun) that was too low. That reportedly resulted in the disqualification and penalization of over thirty (30) horses and trainers.  In 2016, after those horsemen were penalized, RMTC increased the threshold 20 times higher; that did little good for those Florida horsemen who saw a spike in drug positives. Florida was one of twenty states adopting the much heralded National Uniform Medication Program. Uniform rule recommendations not based upon scientific fact present a horrible scenario for individual horsemen, as well as for the industry. What in God's name was the basis for those RMTC recommendations in the first instance? Just this year, two more threshold changes occurred; one for the analgesic detomidine, the other for omeprazole (ulcer medicine).  The originally published RMTC thresholds were apparently not based on actual science at all, tantamount to perhaps being pulled out of a hat and conveniently protected under the confidentiality agreement.  The confidentiality agreement shielded RMTC from scientific scrutiny, the kind to which the New York State Gaming Commission laboratory is subjected, as the industry bares witness to in contested cases where all underlying data is subject to legal and scientific challenge.  RMTC, once receiving financial support from the USTA, saw that support come to an abrupt halt because it ignored the harness industry and the apparent failings discovered in push back by the SOA of NY.  Thankfully, due to that aggressive push back, the New York State Gaming Commission did not follow the RMTC’s recommendations for Banamine and Clenbuterol thresholds. Thus, potentially devastating catastrophes for horsemen as a result of ill-conceived guidelines were avoided in New York. The Florida thoroughbred horsemen did not fare as well, and today the HBPA begs to undo the RMTC uniform rule guidelines. Later, RMTC issued a threshold level for Cobalt which also seemed to be out of touch with actual research being conducted on the drug.  Research principally funded by the USTA conducted by Dr. George Maylin, the New York State Gaming Commission's equine pharmacologist, as well as  renowned  researchers Dr. Karen Malinowski and Dr. Kenneth McKeever of the Equine Science Center at Rutgers University, also exhibited clear problems with RMTC's conclusions and recommendation in this area. After the problematic RMTC litany listed, one would think that Dr. Palmer, the Equine Medical Director, himself not a research scientist, would know better than to look to RMTC for assistance of any kind on the reported Glaucine positives in New York.  This is especially so, since the New York State Gaming Commission's lab should have, and did give consideration to possible environmental contamination in the  levels reported to be found in both blood and urine.  It is reported that the New York lab conducted tests to determine just how much a horse would need to eat of its own bedding to hit the levels allegedly found. Astoundingly, in order to achieve these levels, it was scientifically determined that anywhere from 3 to 10 quarts of shavings would need to be ingested during the relevant time frame.  Getting back to the basic problem with the RMTC selection, it should be noted that RMTC also developed an accreditation process for equine drug testing laboratories. Accreditation costs states money in order to meet the accreditation protocols; money that could have been better spent on research on drugs that heretofore, and still today, go undetected.  Interestingly, when the Indiana Horse Racing Commission sent "audit samples" to a second lab for analysis, the second lab found several "positive tests" which were missed by RMTC's accredited Truesdail Laboratories, Inc. So what is the reason to have the RMTC Task Force study Glaucine? One stated reason is to consider where to assign Glaucine in the system of drug classification.  Well, if it is a bronchial dilator like Albuterol, Clenbuterol, Afrin or Fenspiride, which even RMTC calls threats to the integrity of racing, one would not need great intuitive powers to group the drug in the same class.  One has to wonder if the New York State Gaming Commission's Equine Medical Director, Dr. Palmer, is searching for someone, anyone, to provide the Gaming Commission with some rationale for its departure from the normal process of, after the horse test clean, return of the purse for redistribution and affording the trainer the opportunity to present facts proving contamination, if indeed that is the case.  The industry has now been waiting the six (6) months someone predicted this would take and the latter two items remain open in spite of New York State Gaming Commission regulations.  Therefore, one is prompted to ask if something else is going on here?  Is it the pleading to New York regulators from an interested party when these positives first surfaced, telling them he was getting "crucified in the press"?  Is it the fact that levels as high as 11 ng/ml, coupled with the high number of positives, is just too much for the industry to swallow?  With positives allegedly found in many places now, the self-serving mantra that some tracks claim, that of being the pinnacles of integrity, become indelibly tarnished.  In New York, no substance, other than listed permissive medications, are allowed to be present in a horse's system within seven (7) days of racing.  Glaucine has a half-life of only 6-8 hours and is not a listed substance. What will the marriage of RMTC and Glaucine produce? What is the expected gestation period; 6, 9 or 12 months? Will confidentiality be waived? It should be remembered that an industry which rightfully clamors for the need to detect previously unknown and undetectable substances, whose origins are generally in foreign countries as Fenspiride and Clenbuteral were years ago, must acknowledge that it still wants  new substances  detected. If not, we are wasting a great deal of time and effort for naught.  In sum, there is no "cover" for lack of integrity, and while horsemen do push the envelope as far as they can sometimes, neither regulators nor scientists should demonstrate anything less than the responsibility accorded the roles in which they are vested. Often, however, they seem to have difficulties to getting out of their own way. The New York reported Cobalt positives, originally meted-out as career-ending fines and suspensions, were negotiated out to much lesser penalties, but that was not reported. The multitude of horsemen in New York and elsewhere will continue to watch this Glaucine saga quite closely, and with much scrutiny being given to the process itself, to determine if the motive is genuine, or ulterior.  The prime open question here is: with RMTC's questionable track record and its confidentiality requirement which doesn't lend itself to any scientific scrutiny, what is the exercise trying to achieve? Hopefully, for the good of this game, warts and all, the RMTC group assembled, was not cherry picked for some questionable purpose. The industry deserves the facts based upon solid, verifiable scientifically data for the good of all, and especially for the good of the game itself. Joseph A. Faraldo

Late Thursday afternoon the New York State Gaming Commission began releasing the names of the harness racing trainers of record who have had recent Glaucine positives. Nicholas Surick, Michael “Mickey” Peterson and David Wiskow were the first three names that have been posted. Surick had one positive, Peterson three positives and Wiskow two positives. All six of the positive tests came from horses competing at Monticello Raceway. Apparently the New York State Gaming Commission is only having the horses disqualified and any purses earned returned. There is no mention of any fines or suspensions for the trainers. It has been said that as many as 35 horses involving over 15 different trainers have come up with Glaucine positives.   Licensee: NICHOLAS K. SURICK Licensed As: OWNER-TRAINER-DRIVER Notice Number: MR 33-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record of the #1, "JACKS TO OPEN", who raced in race Seven at Monticello Raceway and tested positive for GLAUCINE, this horse has been disqualified and the purse must be returned. Note that the above data is current as of 5:50 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. Licensee: MICHAEL ( MICKEY ) A. PETERSON Licensed As: OWNER-TRAINER Notice Number: MR 34-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record of the #6, "NATURAL BREEZE", who raced in race Eleven at Monticello Raceway and tested positive for GLAUCINE, this horse has been disqualified and the purse was returned. Note that the above data is current as of 5:51 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. Licensee: MICHAEL ( MICKEY ) A. PETERSON Licensed As: OWNER-TRAINER Notice Number: MR 35-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record of the #3, " LAST CHANCE T", who raced in race Six at Monticello Raceway and tested positive for GLAUCINE, this horse has been disqualified and the purse must be returned. Note that the above data is current as of 5:52 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. Licensee: DAVID J. WISKOW Licensed As: GROOM Notice Number: MR 36-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record of the #2, "MEAN PAULINE", who raced in race Seven at Monticello Raceway and tested positive for GLAUCINE, this horse has been disqualified and the purse must be returned. Note that the above data is current as of 5:52 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. Licensee: MICHAEL ( MICKEY ) A. PETERSON Licensed As: OWNER-TRAINER Notice Number: MR 37-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record on the #5, "LAST CHANCE T", who raced in race Six at Monticello Raceway and tested positive for GLAUCINE,  this horse has been disqualified and the purse must be returned. Note that the above data is current as of 5:53 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. Licensee: DAVID J. WISKOW Licensed As: GROOM Notice Number: MR 38-2016 Racing Type: Harness Track: Monticello Raceway & Mighty M Gaming Notice Date: 04/28/2016 Ruling Type: Other Rule(s): 4120.5 Ruling Text: As trainer of record of the #5, "ROCKETPEDIA", who raced in race One at Monticello Raceway and tested positive for GLAUCINE, this horse has been disqualified and the purse must be returned. Note that the above data is current as of 5:53 AM EDT, Friday, April 29, 2016 and subject to change as more information becomes available. To view the New York State Gaming Commission rulings for 2016 click here.  Harnesslink Media

In the last couple of weeks, Harnesslink has broken the Glaucine story emanating from the drug positives reported on Ron Burke and Julie Miller trained horses. Since then a number of other trainers located in NJ, PA and NY have had positives reported for the same drug. These positives were reported to the New York State Gaming Commission by its own lab, which not so long ago reported positives for a different bronchial dilator and a number of trainers were then subsequently penalized. The current rash of Glaucine positives simply cannot be dismissed out of hand by the regulatory body in NY. The response, to the drug infraction positives reported by the very competent New York State Lab for Ron Burke and Julie Miller, from The Meadowlands and Jeff Gural, was a huge surprise to me as well as many in North America. Instead of doing what Gural has done to every other trainer and driver since he took over The Meadowlands who have either had reported drug positives or some personal peeve, and stand them down from his tracks, Jeff Gural gave Ron Burke and Julie Miller and some others a free pass on a reported positive and did not stand any of them down. It is a complete turnaround from how The Meadowlands and Jeff Gural have treated everyone else in a similar situation based upon nothing more than - a reported positive test. The one known exception of course is a few years ago, if my recollection is correct, you guessed it, one of Jeff's trainers got a positive. In that case, once the vet was blamed all was apparently forgiven. Remember the Canadian owner barred from the Meadowlands because his trainer had a reported positive? I  recognize that it is a great embarrassment for Jeff Gural to have people who train for him charged with drug infractions (as perhaps it was for that Canadian owner), but surely for a drug policy to be effective, it must be applied without fear or favour and to suddenly change what has been custom and policy sends a disturbing message to the wider industry as a whole. Compare the response to the Ron Burke and Julie Miller drug positives reported by the New York Gaming Commission's respected laboratory and the unfair treatment recently meted out to Robert Bresnahan Jr. and a host of others who have had reported positives under Gural 's definition of a positive which is obviously not that of any regulatory body in either NY, NJ or PA.   In Bresnahan's case two horses similarly were said to test positive for EPO or its antibodies in out of competition testing. Testing  done by the Meadowlands, not the New Jersey Racing Commission. There was no verification of any positive by the regulatory body lab in NJ. While Bresnahan has asked for additional testing to be taken to clear his name, so far reportedly denied him, he is unable to race horses at The Meadowlands, Tioga Downs or Vernon Downs. The reason given in the Meadowlands press release was as follows: "As a result of the positive tests, Mr. Bresnahan will be unable to participate at the Meadowlands and sister properties,Tioga Downs and Vernon Downs".   Yes, just a positive test. So Mr Bresnahan was barred immediately, while Ron Burke and Julie Miller are allowed to continue to ply their trade even though the New York Racing Commission has found drug positives on horses trained by both of them. In addition, Gural (Little E LlC stable), unlike the Canadian owner, continues not only to race his horses at the Meadowlands and Yonkers but does so while employing those trainers with the reported positives. One thing that has really intrigued me about the testing regime in place at The Meadowlands is the almost God like reverence given to the testing laboratory of the Hong Kong Jockey Club which is selected for each case The Meadowlands generally uses to toss someone. Where I come from in the Southern Hemisphere, the harness racing industry certainly doesn't place the Hong Kong Jockey Club on the huge pedestal that the Meadowlands does and one has to wonder why the Meadowlands continually shouts their praises from the rooftops at every opportunity. Is it because that lab will call anything a positive even if it doesn't come close to a violation of any rule or regulation? Is it because it denies the accused any right to clear his name because of where the sample was sent? Is there a reason why the Meadowlands did not ask the Commission in New Jersey to at least accompany its personnel to conduct out of competition testing, so that if there was a violation of drug rules, the party would be officially stood down by virtue of a Commission ruling?  As an outsider looking into the North American scene from the Southern Hemisphere, I just cannot get my head around the way people in the same situation such as Bresnahan -- Burke and Miller can be treated so differently. While the solution seems to stop the hypocrisy and role playing as judge, jury and executioner, and work with the Commissions to see to it that trainers and owners, if the latter are involved, are penalized appropriately for violations of the rules governing racing. Perhaps others have some different ideas to resolve this, reinstate all or bar all, but for the moment the stench of hypocrisy and that of a double standard is so strong in this instance that it has wafted all the way down to the Southern Hemisphere under its own steam. JC

The New York Gaming Commission has reported further positives for harness racing trainers in testing samples for the Class 2 Drug Glaucine.   Trainers Mark Ford, Nick Surick,  Daniel Renaud and Milo Zdjelar have all been given notices that horses they raced came up positive for this drug.   This follows last week's announcement that Ron Burke and Julie Miller were hit with similar drug violations.   Please note, that these are only accusations, and that each of these licensees has a right to due process pursuant to New York law and regulations.   Burke & Julie Miller hit with drug violations   Gural issues statement on Glaucine Positives   Glaucine. An interesting mild-psychedelic with a taste for CEVs and euphoria.   Extract from Wikipedia   Glaucine is an alkaloid found in several different plant species in the Papaveraceae family such as Glaucium flavum, Glaucium oxylobum and Corydalis yanhusuo, and in other plants like Croton lechleri in the family Euphorbiaceae.   It has bronchodilator and antiinflammatory effects, acting as a PDE4 inhibitor and calcium channel blocker, and is used medically as an antitussive in some countries. Glaucine may produce side effects such assedation, fatigue, and a hallucinogenic effect characterised by colourful visual images, and has been detected as a novel psychoactive drug.   Mechanism of Action   Glaucine binds to the benzothiazepine site on L-type Ca2+-channels, thereby blocking calcium ion channels in smooth muscle like the human bronchus. Glaucine has no effect on intracellular calcium stores, but rather, does not allow the entry of Ca2+ after intracellular stores have been depleted.[5] Ca2+ influx is a vital component in the process of muscular contraction, and the blocking of this influx therefore reduces the ability of the muscle to contract. In this way, glaucine can prevent smooth muscle from contracting, allowing it to relax.   Glaucine has also been demonstrated to be a dopamine receptor antagonist, favoring D1 and D1-like receptors. It is also a non-competitive selective inhibitor of PDE4 in human bronchial tissue and granulocytes. PDE4 is an isoenzyme that hydrolyzes cyclic AMP to regulate human bronchial tone (along with PDE3). Yet as a PDE4 inhibitor, glaucine possesses very low potency.   For more on Glaucine from Wikipedia   Harnesslink Media    

Early Thursday Harnesslink broke the news on Ron Burke and Julie Miller drug violations. This is the statement that Jeff Gural wrote as a result. Although I am currently on vacation, I have been made aware that apparently several trainers at Yonkers Raceway including Julie Miller and Ron Burke have had horses test positive for glaucine. As you know, Ms. Miller trains several horses for me and Mr. Burke trains Gural Hanover, a horse of which I am a part-owner. Both trainers have already called me and vigorously denied the accusations. At this point, I am unaware if any official action has been taken by the New York Gaming Commission (NYGC) or Yonkers Raceway. I have reached out to officials at the NYGC in an effort to receive more information about the nature of the tests so that we can do our own analysis and draw our own conclusions. I want to be clear; we plan to see what actions, if any, are taken by the NYGC and Yonkers Raceway before we do anything. In addition, representatives of the Standardbred Breeders and Owners Association of New Jersey (SBOANJ) contacted me and have strongly suggested that all of the trainers involved be given their due process rights before any action is taken by my racetracks. The SBOANJ re-affirmed their support for our strong stance on integrity. As such, until an official announcement has been made by the NYGC, Ms. Miller, Mr. Burke, and other trainers whose horses received positive tests that are otherwise in good standing at our three facilities, will be able to race their horses at the Meadowlands. I have directed our own investigator to immediately reach out to Dr. Wan in Hong Kong to see if we can have the many samples we have previously taken from horses trained by Mr. Burke and horses I own that were trained by Ms. Miller to see if glaucine was present in any of those samples. I believe that New York will make the methods used to test for glaucine available to Hong Kong. We are also waiting to see if any other horses in New York test positive for glaucine to see if there is any common element involved, such as the same veterinarians, same feed, same shavings, or the same legitimate feed supplements. Jeff Gural

Two of the leading harness racing trainers in North America were charged with allowing horses to compete with the Class 2 drug Glaucine in their system. In a development that will send shockwaves through an already reeling industry in North America, Ron Burke and Julie Miller have both had horses under their care return positives for Glaucine from races they competed in at a New York racetrack.   Ron Burke has been the dominant trainer on the North American scene for several years now on a money won basis, and these charges have the potential to derail the biggest training operation in harness racing.    Harnessracing.com has received correspondence from attorney Howard Taylor, also a Standardbred owner, regarding a report published Thursday on Harnesslink.com regarding alleged positive tests incurred by trainers Ron Burke and Julie Miller in New York. While Taylor did not identify any trainer by name, he said he has been retained by several trainers whose horses recently had positive tests in New York.   Authorities in New York have been trying for some time to establish a test for Glaucine and it was only recently that the laboratories successfully established such a test.   The Bulgarian pharmaceutical company Sopharma sells glaucine in a tablet form, where a single dose contains 40 mg and the half-life is indicated to be 6–8 hours.   When ingested orally Glaucine has been shown to increase airway conductance in humans, and has been investigated as a treatment for asthma.   Another one of Glaucine’s chief functions is to regulate the formation of fat tissue in the body.   The positives returned today have the potential to be very embarrassing to The New Meadowlands Racetrack where Burke and Miller regularly compete.    While Jeff Gural has single-handedly taken on what he refers to as the drug cheats in the industry, Mr Gural has horses in training with Julie Miller.    His response to the alleged drug infractions will be watched with interest by industry observers.    Here is a link to Wikipedia details on Glaucine   Update - Gural issues statement on Claucine Positives   Harnesslink Media

1 to 7 of 7
1